NEW YORK, April 8 (Reuters) - Takeda Pharmaceutical Co Ltd (4502.T) plans to take back marketing rights to Actos in Canada, northern European nations and Turkey from Eli Lilly & Co (LLY.N) and start selling the diabetes drug in those places itself as soon as this year, the financial daily Nikkei said in its Thursday edition.
